BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22749946)

  • 1. Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.
    Echeverry-Alzate V; Tuda-Arízcun M; Bühler KM; Santos Á; Giné E; Olmos P; Gorriti MÁ; Huertas E; Rodríguez de Fonseca F; López-Moreno JA
    Neuropharmacology; 2012 Nov; 63(6):927-35. PubMed ID: 22749946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption.
    Kuzmin A; Stenback T; Liljequist S
    Eur J Pharmacol; 2008 Apr; 584(2-3):352-6. PubMed ID: 18339371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the expression of transthyretin and protein kinase Cγ genes in the prefrontal cortex in response to naltrexone.
    Yu J; Halder D; Baek MN; Das ND; Choi MR; Oh DY; Choi IG; Jung KH; Chai YG
    Neurosci Lett; 2011 Jan; 488(3):288-93. PubMed ID: 21111029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats.
    Czachowski CL; Delory MJ
    Psychopharmacology (Berl); 2009 Jun; 204(2):335-48. PubMed ID: 19153715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex.
    Echeverry-Alzate V; Giné E; Bühler KM; Calleja-Conde J; Olmos P; Gorriti MA; Nadal R; Rodríguez de Fonseca F; López-Moreno JA
    Br J Pharmacol; 2014 Jun; 171(12):3023-36. PubMed ID: 24527678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol-reinforced behaviour in the rat: effects of naltrexone.
    Bienkowski P; Kostowski W; Koros E
    Eur J Pharmacol; 1999 Jun; 374(3):321-7. PubMed ID: 10422776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of nucleus accumbens connectivity by alcohol drinking and naltrexone in alcohol-preferring rats: A manganese-enhanced magnetic resonance imaging study.
    Dudek M; Canals S; Sommer WH; Hyytiä P
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):445-55. PubMed ID: 26851200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes.
    Navarrete F; Rubio G; Manzanares J
    Addict Biol; 2014 Sep; 19(5):862-73. PubMed ID: 23573810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.
    Heyser CJ; Moc K; Koob GF
    Neuropsychopharmacology; 2003 Aug; 28(8):1463-71. PubMed ID: 12700689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding.
    Williams KL
    Alcohol Clin Exp Res; 2007 Jan; 31(1):39-47. PubMed ID: 17207100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.
    Escher T; Mittleman G
    Addict Biol; 2006 Mar; 11(1):55-63. PubMed ID: 16759337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
    Heyser CJ; Schulteis G; Durbin P; Koob GF
    Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation.
    Hölter SM; Landgraf R; Zieglgänsberger W; Spanagel R
    Alcohol Clin Exp Res; 1997 Aug; 21(5):862-8. PubMed ID: 9267536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
    Phillips TJ; Wenger CD; Dorow JD
    Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
    Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.
    Viudez-Martínez A; García-Gutiérrez MS; Fraguas-Sánchez AI; Torres-Suárez AI; Manzanares J
    Br J Pharmacol; 2018 Aug; 175(16):3369-3378. PubMed ID: 29859012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
    Kuzmin A; Kreek MJ; Bakalkin G; Liljequist S
    Neuropsychopharmacology; 2007 Apr; 32(4):902-10. PubMed ID: 16880770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.
    Heidbreder CA; Andreoli M; Marcon C; Hutcheson DM; Gardner EL; Ashby CR
    Addict Biol; 2007 Mar; 12(1):35-50. PubMed ID: 17407496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.
    Ji D; Gilpin NW; Richardson HN; Rivier CL; Koob GF
    Behav Pharmacol; 2008 Feb; 19(1):1-12. PubMed ID: 18195589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.